Safety, Tolerability and Pharmacokinetics of Eptinezumab in Healthy Chinese Subjects
Clinical trial NCT05045781 · COMPLETED
Trial details
- NCT number
- NCT05045781
- Sponsor
- H. Lundbeck A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-20
- Primary completion
- 2021-07-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.